Information Provided By:
Fly News Breaks for October 28, 2015
ICLR
Oct 28, 2015 | 08:54 EDT
SunTrust attributes the decline in ICON's 9ICLR) stock after its results to its slightly lower than expected Q3 revenue fueling concerns about the company's ability to grow ex-Pfizer (PFE). However, the firm thinks the concerns are overdone given what it sees as the company's 1.4x non-large pharma book:bill and 8% ex-PFE growth. The firm doesn't believe that the stock can drop significantly from current levels. It reiterates a Buy rating on the shares.
News For ICLR From the Last 2 Days
ICLR
ICLR
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.